Browsing category:

Anti-Retroviral / Anti-HIV


Atazanavir Sulfate, CAS# 229975-97-7, is essential in the management of HIV in affected patients. As an inhibitor of the HIV-1 protease, it is often used in combination with other antiretroviral medications to treat HIV-1 infected patients. LGM Pharma is a provider of the API for research and development. With a trade name Reyataz (Bristol-Myers Squibb),[…]

Read More

AIDS is a global pandemic whose cure has eluded scientists and doctors for more than 2 decades. Acquired immunodeficiency syndrome (AIDS) is caused by the Human Immunodeficiency Virus (HIV) which progressively undermines the strength of the immune system until such a time that the body becomes incapable of fighting off infections and vulnerable to opportunistic[…]

Read More

Peramivir is one of the most effective drugs that can be used to treat patients suffering from swine flu. During the H1N1 influenza epidemic crisis in 2009, the US Food and Drug Administration (FDA) awarded Peramivir with the Emergency Use Authorization. This particular drug was given special permission to be used in cases when all[…]

Read More

Darunavir Ethanolate CAS# 635728-49-3 is a second-generation protease inhibitor (PIs), designed specifically to overcome problems with the older agents in this class, such as indinavir. Darunavir was designed to form robust interactions with the protease enzyme from many strains of HIV, including strains from treatment-experienced patients with multiple resistance mutations to PIs. Darunavir is always[…]

Read More

This website uses cookies. By using our site, you agree to our terms of service